Stifel Nicolaus Reaffirms “Hold” Rating for HCP, Inc. (HCP)
Stifel Nicolaus reissued their hold rating on shares of HCP, Inc. (NYSE:HCP) in a report released on Wednesday. The brokerage currently has a $30.00 price target on the real estate investment trust’s stock.
Several other research analysts also recently commented on HCP. UBS AG upgraded shares of HCP from an underperform rating to an outperform rating in a report on Wednesday, June 14th. Zacks Investment Research downgraded shares of HCP from a hold rating to a sell rating in a report on Tuesday, October 3rd. Morgan Stanley dropped their target price on shares of HCP from $31.00 to $29.00 and set an equal weight rating on the stock in a report on Monday, September 25th. BidaskClub downgraded shares of HCP from a hold rating to a sell rating in a report on Thursday, July 27th. Finally, KeyCorp reiterated a hold rating on shares of HCP in a report on Sunday, September 17th. Four equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and one has issued a buy rating to the stock. The company currently has an average rating of Hold and an average target price of $31.27.
HCP (NYSE HCP) opened at 26.92 on Wednesday. The stock has a market capitalization of $12.62 billion, a PE ratio of 18.35 and a beta of 0.38. The firm has a 50-day moving average of $28.90 and a 200-day moving average of $30.74. HCP has a 52-week low of $26.47 and a 52-week high of $34.02.
HCP (NYSE:HCP) last announced its earnings results on Tuesday, August 1st. The real estate investment trust reported $0.48 EPS for the quarter, topping the consensus estimate of $0.47 by $0.01. The firm had revenue of $458.90 million for the quarter, compared to the consensus estimate of $456.29 million. HCP had a net margin of 32.16% and a return on equity of 9.96%. The business’s quarterly revenue was down 14.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.71 EPS. On average, equities analysts expect that HCP will post $1.35 EPS for the current year.
Several institutional investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of HCP by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 67,505,742 shares of the real estate investment trust’s stock valued at $2,111,579,000 after acquiring an additional 1,557,716 shares in the last quarter. BlackRock Inc. boosted its position in shares of HCP by 1.3% during the 2nd quarter. BlackRock Inc. now owns 46,580,421 shares of the real estate investment trust’s stock valued at $1,488,710,000 after acquiring an additional 599,578 shares in the last quarter. State Street Corp boosted its position in shares of HCP by 0.3% during the 2nd quarter. State Street Corp now owns 27,363,119 shares of the real estate investment trust’s stock valued at $874,524,000 after acquiring an additional 74,972 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of HCP by 2.3% during the 2nd quarter. JPMorgan Chase & Co. now owns 23,442,708 shares of the real estate investment trust’s stock valued at $749,230,000 after acquiring an additional 521,915 shares in the last quarter. Finally, Daiwa Securities Group Inc. boosted its position in shares of HCP by 6.9% during the 2nd quarter. Daiwa Securities Group Inc. now owns 10,610,722 shares of the real estate investment trust’s stock valued at $339,119,000 after acquiring an additional 687,228 shares in the last quarter. Institutional investors and hedge funds own 89.60% of the company’s stock.
HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.
Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.